EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Itama Ranoraya Tbk's Enterprise Value is Rp1,445,574 Mil.
PT Itama Ranoraya Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was Rp-371,119 Mil. Therefore, PT Itama Ranoraya Tbk's EV-to-FCF for today is -3.90.
The historical rank and industry rank for PT Itama Ranoraya Tbk's EV-to-FCF or its related term are showing as below:
ISX:IRRA'
s EV-to-FCF Range Over the Past 10 Years
Min: -174.56 Med: -10.22 Max: 11103.68
Current: -3.88
During the past 10 years, the highest EV-to-FCF of PT Itama Ranoraya Tbk was 11103.68. The lowest was -174.56. And the median was -10.22.
ISX:IRRA's EV-to-FCF is ranked worse than 100% of 74
companies
in the Medical Distribution industry
Industry Median: 17.415
vs ISX:IRRA: -3.88
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Itama Ranoraya Tbk's PE Ratio (TTM) for today is calculated as:
PT Itama Ranoraya Tbk's share price for today is Rp378.00.
PT Itama Ranoraya Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp42.589.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Itama Ranoraya Tbk EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PT Itama Ranoraya Tbk's EV-to-FCF falls into.
PT Itama Ranoraya Tbk's current Enterprise Value is Rp1,445,574 Mil.
PT Itama Ranoraya Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-371,119 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Itama Ranoraya Tbk (ISX:IRRA) has a EV-to-FCF of -3.90 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Itama Ranoraya Tbk and its competitors. According to the industry distribution chart, PT Itama Ranoraya Tbk ranks #999999 out of 74 companies in the Medical Distribution industry.
Is PT Itama Ranoraya Tbk's EV-to-FCF too high?
PT Itama Ranoraya Tbk's current EV-to-FCF is -3.90. Based on the distribution chart, PT Itama Ranoraya Tbk ranks #999999 out of 74 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, PT Itama Ranoraya Tbk has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Itama Ranoraya Tbk's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, PT Itama Ranoraya Tbk ranks #999999 out of 74 companies for EV-to-FCF. This places PT Itama Ranoraya Tbk in the lower half of its industry. The industry median EV-to-FCF is 17.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.42, based on 74 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Itama Ranoraya Tbk and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Itama Ranoraya Tbk's current EV-to-FCF is -3.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Itama Ranoraya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk (ISX:IRRA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp537.04, compared to a current price of Rp378.00 — trading 29.6% below its estimated fair value. The current EV-to-FCF is -3.90. PT Itama Ranoraya Tbk's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PT Itama Ranoraya Tbk (ISX:IRRA), the current EV-to-FCF is -3.90 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued.
The current stock price of Rp378.00 is trading 29.6% below its estimated GF Value™ of Rp537.04.
GuruFocus considers PT Itama Ranoraya Tbk to be Possible Value Trap.
Key valuation signals for ISX:IRRA:
EV-to-FCF: -3.90
GF Value™: Rp537.04 vs. price of Rp378.00 (29.6% below fair value)
No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
81GF Score
Get the complete analysis for ISX:IRRA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:IRRA has been successfully added to your 
